Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 17916737 | ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES, TRIFLURIDINE AND TIPIRACIL | A61P, A61K | Apr 21, 2021 | |
| 17234618 | Humanized anti-complement factor Bb antibodies | C07K, A61K | Apr 18, 2021 | Feb 7, 2022 |
| 17224861 | USES OF A DUAL V REGION ANTIBODY-LIKE PROTEIN | C07K | Apr 6, 2021 | Nov 16, 2021 |
| 17925088 | (1 H-Indol-5-YL)Acrylamide Derivatives as Inhibitors of Tead Proteins and the Hippo-YAP1/TAZ Signaling Cascade for the Treatment of Cancer | A61P, C07D, C07F | Apr 5, 2021 | |
| 17915344 | INJECTION DEVICE STORAGE CONTAINER | F25D, A61M | Mar 31, 2021 | |
| 17914600 | Injection Device with Needle Obscuring Element | A61M | Mar 31, 2021 | |
| 17916144 | Injector Device | A61M | Mar 30, 2021 | |
| 17914897 | Injector Device | A61M | Mar 30, 2021 | |
| 17915310 | Injector Device | A61M | Mar 30, 2021 | |
| 17215674 | Site-specific glycoengineering of targeting moieties | A61K, C07K | Mar 28, 2021 | Jul 10, 2023 |
| 17215163 | Immunoglobulin variable domains | C07K | Mar 28, 2021 | May 2, 2022 |
| 17215039 | Immunoglobulin variable domains | C07K | Mar 28, 2021 | Apr 25, 2022 |
| 17215039 | Immunoglobulin variable domains | C07K | Mar 28, 2021 | Apr 25, 2022 |
| 17908190 | SPLIT CH2 DOMAINS | C07K | Mar 28, 2021 | |
| 17215121 | Immunoglobulin variable domains | C07K | Mar 28, 2021 | Oct 31, 2022 |
| 17914480 | Electronic System for a Drug Delivery Device | A61M | Mar 24, 2021 | |
| 17928137 | Electronic system for a drug delivery device and drug delivery device | A61M | Mar 24, 2021 | |
| 18025477 | Electronic System for a Drug Delivery Device | A61M | Mar 24, 2021 | |
| 17914507 | Electronic system for a drug delivery device and drug delivery device | A61M | Mar 24, 2021 | |
| 17914501 | Switch Assembly for an Electronic System of a Drug Delivery Device | A61M | Mar 24, 2021 |